NULL

Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

CHINA

India

Indonesia

Japan

Kore

Malaysia

Philippines

Bluevac-3

Inactivated bluetongue virus, serotype 3, strain BTV-3/NET2023

Available in:

  • 250mls vial

Cattle
For active immunisation of cattle to reduce the viraemia against the serotype 3 of the bluetongue virus.
Onset of immunity: 21 days after completion of the primary vaccination scheme.
Duration of immunity: not established yet.

 

Sheep
For active immunisation of sheep to reduce the viraemia, preventing mortality and to reduce clinical signs caused by the serotype 3 of the bluetongue virus.
Onset of immunity: 21 days after completion of the primary vaccination scheme.
Duration of immunity: not established yet.

Fertility: The safety and efficacy of the vaccines has not been established in breeding males (sheep and cattle).

Target species:

  • cattle icon Cattle
  • sheep icon Sheep

How to use

Administration – Subcutaneous use.

  • Primary vaccination, can be used during pregnancy in ewes and cows.
  • Cattle from 2 month of age: Administer two doses of 4 ml subcutaneously 3 weeks apart
  • Sheep from 2 months of age: Administer two doses of 2 mL subcutaneously 3 weeks apart
  • Revaccination not yet established
  • Withdrawal: Zero days

Prescription decisions are for the person issuing the prescription alone. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet or on request.

Legal Category: UK POMV

SPC

Why choose
Bluevac

In cattle Bluevac-3

Reduces the viraemia (the presence of virus in the blood)

In sheep Bluevac-3

Reduces the viraemia, preventing mortality and reduces clinical signs caused by the serotype 3 of the bluetongue virus

Convenience

Can be administered during pregnancy to ewes and female cattle

Pack options

Zero milk and meat withdrawal

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.